Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;19(2):861-8.
doi: 10.1007/s10856-007-0166-6. Epub 2007 Jul 31.

The behavior of osteoblast-like cells on various substrates with functional blocking of integrin-beta1 and integrin-beta3

Affiliations

The behavior of osteoblast-like cells on various substrates with functional blocking of integrin-beta1 and integrin-beta3

M C Siebers et al. J Mater Sci Mater Med. 2008 Feb.

Abstract

This study was designed to examine the influence of integrin subunit-beta1 and subunit-beta3 on the behavior of primary osteoblast-like cells, cultured on calcium phosphate (CaP)-coated and non coated titanium (Ti). Osteoblast-like cells were incubated with specific monoclonal antibodies against integrin-beta1 and integrin-beta3 to block the integrin function. Subsequently, cells were seeded on Ti discs, either non coated or provided with a 2 microm carbonated hydroxyapatite coating using Electrostatic Spray Deposition. Results showed that on CaP coatings, cellular attachment was decreased after a pre-treatment with either anti-integrin-beta1 or anti-integrin-beta3 antibodies. On Ti, cell adhesion was only slightly affected after a pre-treatment with anti-integrin-beta3 antibodies. Scanning electron microscopy showed that on both types of substrate, cellular morphology was not changed after a pre-treatment with either antibody. With quantitative PCR, it was shown for both substrates that mRNA expression of integrin-beta1 was increased after a pre-treatment with either anti-integrin-beta1 or anti-integrin-beta3 antibodies. Furthermore, after a pre-treatment with either antibody, mRNA expression of integrin-beta3 and ALP was decreased, on both types of substrate. In conclusion, osteoblast-like cells have the ability to compensate to great extent for the blocking strategy as applied here. Still, integrin-beta1 and beta3 seem to play different roles in attachment, proliferation, and differentiation of osteoblast-like cells, and responses on CaP-coated substrates differ to non coated Ti. Furthermore, the influence on ALP expression suggests involvement of both integrin subunits in signal transduction for cellular differentiation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cellular attachment in the first run. (A) and (B) CaP-coated substrates derived with Electrostatic Spray Deposition (ESD); (C) and (D) non-coated Ti. * indicates a significant difference between the control group and the experimental group with the pre-treatment with anti-integrin-β1 antibodies. indicates a significant difference between the control group and the experimental group that was pre-treated with anti-integrin-β3 antibodies
Fig. 2
Fig. 2
Cellular attachment in the second run. (A) and (B) CaP-coated substrates derived with Electrostatic Spray Deposition (ESD); (C) and (D) non-coated Ti. * indicates a significant difference between the control group and the experimental group with the pre-treatment with anti-integrin-β1 antibodies. # indicates a significant difference between the control group and the experimental group that was pre-treated with anti-integrin-β3 antibodies
Fig. 3
Fig. 3
Scanning electron micrographs of osteoblast-like cells on CaP-coated (A, B, and C) substrates, and non-coated (D, E, and F) Ti substrates after 1 day of culture. There were no morphological differences between the control group (A and D), or the experimental groups that were either pre-treated with anti-integrin-β1 antibodies (B and E), or anti-integrin-β3 antibodies (C and F)

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1034/j.1600-0501.1998.090407.x', 'is_inner': False, 'url': 'https://doi.org/10.1034/j.1600-0501.1998.090407.x'}, {'type': 'PubMed', 'value': '9760901', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9760901/'}]}
    2. S. VERCAIGNE, J. G. C. WOLKE, I. NAERT and J. A. JANSEN, Clin. Oral Impl. Res.9 (1998) 261 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1034/j.1600-0501.2000.011004314.x', 'is_inner': False, 'url': 'https://doi.org/10.1034/j.1600-0501.2000.011004314.x'}, {'type': 'PubMed', 'value': '11168224', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11168224/'}]}
    2. S. VERCAIGNE, J. G. C. WOLKE, I. NAERT and J. A. JANSEN, Clin. Oral Impl. Res.11 (2000) 314 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1006/cbir.1996.0110', 'is_inner': False, 'url': 'https://doi.org/10.1006/cbir.1996.0110'}, {'type': 'PubMed', 'value': '9046103', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9046103/'}]}
    2. M. CASTOLDI, M. PISTONE, C. CARUSO, A. PUDDU, C. FILANTI, D. PICCINI, C .TACCHETTI and P. MANDUCA, Cell Biol. Int.21 (1997) 7 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0142-9612(99)00242-2', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0142-9612(99)00242-2'}, {'type': 'PubMed', 'value': '10711964', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10711964/'}]}
    2. K. ANSELME, Biomaterials21 (2000) 667 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S8756-3282(99)00007-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/s8756-3282(99)00007-1'}, {'type': 'PubMed', 'value': '10221544', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10221544/'}]}
    2. G. B. SCHNEIDER, S. W. WHITSON and L. F. COOPER, Bone24 (1999) 321 - PubMed

Publication types

LinkOut - more resources